Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference

Rhea-AI Summary

Senti Biosciences (Nasdaq: SNTI) announced that CEO and co‑founder Timothy Lu, MD, PhD will present at Chardan's 9th Annual Genetic Medicines Conference on October 21, 2025 in New York.

The live webcast of the presentation will be available on the company’s Investors > Events page and management will be available for one‑on‑one investor meetings for registered attendees.

Live webcast presentation on Tuesday, October 21st at 11:35 AM ET

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, MD, PhD, CEO and Co-Founder of Senti Biosciences will present at Chardan’s 9^th Annual Genetic Medicines Conference being held on October 21, 2025 in New York, NY.

In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website.

A live webcast of the presentation will be available on the Events page of Investors section of the Company’s website (www.sentibio.com).

About Senti Bio

Senti Bio is a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases. To achieve this, Senti Bio is leveraging its synthetic biology platform to engineer Gene Circuits into new medicines with enhanced precision and control. These Gene Circuits are designed to precisely kill cancer cells, to spare healthy cells, to increase specificity to target tissues, and/or to be controllable even after administration. The Company’s wholly-owned pipeline is comprised of cell therapies engineered with Gene Circuits to target challenging liquid and solid tumor indications. Senti’s Gene Circuits have been shown preclinically to work in both NK and T cells. Senti Bio has also preclinically demonstrated the potential breadth of Gene Circuits in other modalities and diseases outside of oncology, and continues to advance these capabilities through partnerships.

Availability of Other Information About Senti Biosciences, Inc.

For more information, please visit the Senti Bio website at www.sentibio.com or follow Senti Bio on X (@SentiBio) and LinkedIn (Senti Biosciences). Investors and others should note that we communicate with our investors and the public using our company website (www.sentibio.com), including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on X and LinkedIn. The information that we post on our website or on X or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Investor Contact:
JTC Team, LLC
Jenene Thomas
(908) 824-0775
SNTI@jtcir.com

FAQ

When will Senti Biosciences (SNTI) present at Chardan’s 9th Annual Genetic Medicines Conference?

Senti Biosciences will present on October 21, 2025 at 11:35 AM ET.

How can investors watch the SNTI presentation on October 21, 2025?

A live webcast will be available on the company’s Investors > Events page at www.sentibio.com.

Will Senti Biosciences management meet with investors at the October 21, 2025 conference?

Yes; management will be available for one‑on‑one meetings with qualified, registered investor attendees.

Who is presenting for Senti Biosciences (SNTI) at the conference?

Timothy Lu, MD, PhD, CEO and co‑founder, will deliver the presentation.

Where is Chardan’s 9th Annual Genetic Medicines Conference being held for the SNTI presentation?

The conference is being held in New York, NY on October 21, 2025.